Dr. Michael Kim retweetet

Dr. @michaelkimMD presenting our work at #CARO2021 looking at SBRT use in H&N cancers as a boost after definitive radiotherapy.
For now, we recommend its use only in clinical trial setting.
Manuscript coming soon.
@DalhousieU @UofTDRO @caro_acro_ca


English




















